Christopher Hansen is listed as an executive officer and director on 12 SEC Form D filings by 4 issuers between May 2014 and Jul 2025: PharmaCielo Holdings Ltd. (Toronto, Ontario, Canada (as filed: A6) — pharmaceuticals — 2015–2016; $6.32M reported sold to 108 investors), Cryomass Technologies, Inc. (Denver, CO — industry reported as "Other" — 2018–2020; $2.45M reported sold to 15 investors), Vida Cannabis Corp. (Ottawa, Ontario, Canada (as filed: A6) — industry reported as "Other" — 2014; $440K reported sold to 17 investors) and NatBridge Resources Ltd. (Burnaby, British Columbia, Canada (as filed: A1) — other energy — 2024–2025; $103K reported sold to 6 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $9.31M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 7 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 12 public filings for Christopher Hansen and found 19 differences, 4 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.